Pharmaceutical stocks, including Pfizer (NYSE: PFE ... rebounded after Wall Street analysts highlighted the significant legal challenges the order would face. The pharmaceutical industry has ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

According to InvestingPro data, the company faces significant financial challenges ... ITIL agreed to cover a transaction fee and Pfizer’s legal expenses. Iterum’s CEO, Corey Fishman ...

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

The Pfizer Middle East, Russia and Africa (MERA) Maternal Immunization Summit: Born Ready brought together more than 80 ...

The European Court of Justice has upheld a transparency challenge over undisclosed text messages between EU Commission ...

positioning it well for future growth despite recent market challenges. The legal battle began in 2020 when Pfizer accused SK bioscience of infringing on the composition patent of its own vaccine ...

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story ...

EU Commission loses on all counts in Pfizergate legal case The EU’s top court annulled the Commission’s decision to deny the newspaper New York Times access to messages exchanged between President ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... These frameworks provide patients and developers with legal protection by simplifying liability standards for flawed ...